“…The classical GBS is considered the most common and most severe acute paralytic neuropathy with a worldwide overall incidence of about 1.3:100 000 per annum (Willison, Jacobs, & van Doorn, ) and about 0.6:100 000 in children <15 years of age (McGrogan, Madle, Seaman, & de Vries, ). None the less, a misdiagnosis of GBS in arsenic polyneuropathy is not infrequent, and there are several reports of arsenic‐induced sensorimotor neuropathy mimicking GBS with or without any systemic manifestation of arsenic intoxication affecting groups of arsenic‐exposed people (Barton & McLean, ; Donofrio et al, ; Franzblau & Lilis, ; Gear, ; Jalal, Fernandez, & Menon, ; Kim et al, ; Mathew, Vale, & Adcock, ). In 2011, the crude incidence rate of GBS in Bangladesh, a country where anthropogenic environmental arsenic contamination is endemic, in children <15 years of age, appeared to be 2.5× to 4× higher than that reported in the literature (Islam et al, ).…”